MAECELL
LIVE

Serial Number

99478491

Owner

Genani Corporation

Attorney

Alisa C. Simmons

Filing Date

Nov 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MAECELL Trademark

Serial Number: 99478491

MAECELL is a trademark filed by Genani Corporation on November 4, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Genani Corporation

233 East Erie Street
Chicago, IL 60611

Entity Type: 03

Trademark Details

Filing Date

November 4, 2025

Registration Date

Not Registered

Published for Opposition

April 14, 2026

Goods & Services

Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the treatment of Amyotrophic lateral sclerosis; Pharmaceutical preparations for repair of organs damaged by trauma, burns, drugs, radiation, hypoxia, and explosive device; Pharmaceutical preparations for reversing effects of aging; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; Pharmaceutical preparations for the treatment of treatment of degenerative diseases and disorders of joints, heart, cardiovascular system, brain, spinal cord, ligaments, muscles, kidneys, liver, skin and lungs; Pharmaceutical preparations for the treatment of connective tissue diseases and disorders; Pharmaceutical preparations for the prevention of prevention and treatment of vascular diseases or disorders; Pharmaceutical preparations for the treatment of neurological disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of cardiopulmonary and pulmonary related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular related diseases or disorders; Pharmaceutical preparations for skin care; Astringents for medicinal purposes; Pharmaceutical skin lotions; Stem cells for medical purposes; Pharmaceutical preparations for the treatment and prevention of vascular diseases and disorders

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 17, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 4, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2025 NWOS
NEW APPLICATION ENTERED
Nov 4, 2025 NWAP